CLINICAL TRIALS PROFILE FOR IMVEXXY

All Clinical Trials for IMVEXXY

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05457972 ↗	Postpartum Vaginal Estrogen	Not yet recruiting	University Hospitals Cleveland Medical Center	Phase 4	2022-08-01	Sexual dysfunction is very common in the postpartum period and is more common in people who breastfeed or pump. This research study was designed to help determine whether postpartum patients who use vaginal estrogen cream while breastfeeding have improved sexual function compared to postpartum patients who do not.
NCT05617820 ↗	Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy	Not yet recruiting	Teva Pharmaceuticals USA	Phase 3	2022-11-08	Randomized, double-blind, placebo-controlled, parallel-designed, multiple-site, bioequivalence study with clinical endpoints.

Clinical Trial Conditions for IMVEXXY

Condition Name

Condition Name for IMVEXXY
Intervention	Trials
Dyspareunia	1
Postpartum Sexual Dysfunction	1
Vaginal Atrophy	1
Breastfeeding	1

Condition MeSH

Condition MeSH for IMVEXXY
Intervention	Trials
Atrophy	2
Dyspareunia	1

Clinical Trial Locations for IMVEXXY

Trials by Country

Trials by Country for IMVEXXY
Location	Trials
United States	4

Trials by US State

Trials by US State for IMVEXXY
Location	Trials
Kansas	1
Georgia	1
Florida	1
Ohio	1

Clinical Trial Progress for IMVEXXY

Clinical Trial Phase

Clinical Trial Phase for IMVEXXY
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1

Clinical Trial Status

Clinical Trial Status for IMVEXXY
Clinical Trial Phase	Trials
Not yet recruiting	2

Clinical Trial Sponsors for IMVEXXY

Sponsor Name

Sponsor Name for IMVEXXY
Sponsor	Trials
Teva Pharmaceuticals USA	1
University Hospitals Cleveland Medical Center	1

Sponsor Type

Sponsor Type for IMVEXXY
Sponsor	Trials
Industry	1
Other	1